FNDC5 and chronic obstructive pulmonary disease: In patients with COPD, serum irisin levels were significantly correlated with diffusing capacity of lung for carbon monoxide/alveolar volume (DLCO/VA) and percentage of low-attenuation area (LAA%) (81).